Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 18.89%-653.54M | ---- | 83.08%-805.77M | ---- | -8,694.45%-4.76B | ---- | 85.48%-54.14M | ---- | -112.13%-372.88M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | 99.60%-28K | ---- | 74.19%-7.09M | ---- | -117.26%-27.45M | ---- | 13.75%-12.63M | ---- | -3,259.63%-14.65M |
| Attributable subsidiary (profit) loss | ---- | 8.03%323K | ---- | -62.20%299K | ---- | 85.25%791K | ---- | -43.37%427K | ---- | -84.33%754K |
| Impairment and provisions: | ---- | -44.94%194.14M | ---- | -91.69%352.59M | ---- | 3,854.04%4.24B | ---- | 46.83%107.31M | ---- | -84.38%73.09M |
| -Impairment of property, plant and equipment (reversal) | ---- | ---- | ---- | ---- | ---- | -41.09%2.21M | ---- | --3.76M | ---- | ---- |
| -Impairmen of inventory (reversal) | ---- | ---- | ---- | -96.42%2.5M | ---- | --69.83M | ---- | ---- | ---- | -95.52%137K |
| -Other impairments and provisions | ---- | -44.54%194.14M | ---- | -91.61%350.08M | ---- | 3,927.85%4.17B | ---- | 41.96%103.56M | ---- | 27.95%72.95M |
| Revaluation surplus: | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 108.93%1.68M | ---- | 94.58%-18.87M |
| -Derivative financial instruments fair value (increase) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -79.74%232K | ---- | 101.07%1.15M |
| -Other fair value changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 107.26%1.45M | ---- | 91.68%-20.01M |
| Asset sale loss (gain): | ---- | 143.70%52K | ---- | -101.83%-119K | ---- | --6.5M | ---- | ---- | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | ---- | 143.70%52K | ---- | -101.83%-119K | ---- | --6.5M | ---- | ---- | ---- | ---- |
| Depreciation and amortization: | ---- | -17.09%35.12M | ---- | -17.11%42.37M | ---- | -3.66%51.11M | ---- | -3.98%53.05M | ---- | 3.05%55.25M |
| -Depreciation | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 4.99%48.14M |
| Financial expense | ---- | 27.51%354.06M | ---- | 18.55%277.66M | ---- | 5.75%234.21M | ---- | 30.28%221.48M | ---- | 14.95%170M |
| Exchange Loss (gain) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 4,209.05%277.9M |
| Special items | ---- | -57.77%1.04M | ---- | -62.31%2.47M | ---- | 120.12%6.56M | ---- | -108,746.67%-32.59M | ---- | -99.96%30K |
| Operating profit before the change of operating capital | ---- | 49.98%-68.83M | ---- | 44.14%-137.59M | ---- | -186.55%-246.31M | ---- | 66.79%284.59M | ---- | -21.93%170.63M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | -25.31%25.33M | ---- | 81.53%33.91M | ---- | -85.33%18.68M | ---- | -48.43%127.32M | ---- | 283.79%246.89M |
| Accounts receivable (increase)decrease | ---- | 121.65%11.21M | ---- | 64.95%-51.78M | ---- | 48.23%-147.7M | ---- | 71.11%-285.32M | ---- | -273.28%-987.67M |
| Accounts payable increase (decrease) | ---- | -103.71%-4.1M | ---- | -43.04%110.48M | ---- | -29.02%193.95M | ---- | -71.58%273.26M | ---- | 165.17%961.57M |
| prepayments (increase)decrease | ---- | 175.59%18.57M | ---- | 16.16%-24.56M | ---- | 89.54%-29.3M | ---- | -20.88%-280.06M | ---- | 59.42%-231.69M |
| Cash from business operations | ---- | 74.38%-17.82M | ---- | 66.99%-69.54M | ---- | -275.87%-210.67M | ---- | -25.00%119.79M | ---- | 141.09%159.72M |
| Other taxs | ---- | -28.26%165K | ---- | 114.22%230K | ---- | 56.54%-1.62M | ---- | 53.11%-3.72M | ---- | 67.03%-7.94M |
| Special items of business | -127.88%-2.18M | ---- | 104.16%7.81M | ---- | -224.81%-187.97M | ---- | 148.07%150.6M | ---- | -196.18%-313.31M | ---- |
| Net cash from operations | -127.88%-2.18M | 74.53%-17.66M | 104.16%7.81M | 67.35%-69.31M | -224.81%-187.97M | -282.90%-212.29M | 148.07%150.6M | -23.53%116.07M | -196.18%-313.31M | 136.77%151.79M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | -80.95%4K | -99.84%28K | 425.00%21K | -32.82%17.18M | -99.89%4K | 36.74%25.58M | -10.25%3.78M | 5,229.06%18.71M | -39.31%4.21M | -19.50%351K |
| Loan receivable (increase) decrease | ---- | 96.55%-92K | 104.35%105K | -599.06%-2.67M | -358.52%-2.41M | 101.07%534K | --933K | -440.33%-49.84M | ---- | --14.65M |
| Decrease in deposits (increase) | ---- | ---- | ---- | ---- | ---- | 148.76%169.43M | ---- | 28.05%-347.46M | ---- | -5,569.08%-482.92M |
| Sale of fixed assets | ---- | 21.24%411K | --131K | -88.06%339K | ---- | --2.84M | --557K | ---- | ---- | --1K |
| Purchase of fixed assets | 28.27%-274K | 23.69%-380K | ---382K | -447.25%-498K | ---- | 95.13%-91K | 94.20%-51K | 88.97%-1.87M | 94.08%-880K | 4.53%-16.93M |
| Cash on investment | --123K | ---- | ---- | ---- | 211.28%201.96M | ---- | -150.26%-181.48M | ---- | --361.09M | ---- |
| Other items in the investment business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -99.78%115K |
| Net cash from investment operations | -17.60%-147K | -100.23%-33K | -100.06%-125K | -92.76%14.36M | 213.21%199.55M | 152.12%198.29M | -148.37%-176.26M | 21.51%-380.46M | 4,769.75%364.43M | -1,185.70%-484.74M |
| Net cash before financing | -130.24%-2.33M | 67.81%-17.69M | -33.64%7.69M | -292.56%-54.95M | 145.14%11.59M | 94.71%-14M | -150.22%-25.67M | 20.59%-264.39M | -83.92%51.11M | 9.56%-332.95M |
| Cash flow from financing activities | ||||||||||
| New borrowing | ---- | -85.11%12M | ---- | 54.41%80.6M | ---- | -91.17%52.2M | -11.65%18.79M | -60.82%590.86M | -96.99%21.27M | 96.55%1.51B |
| Refund | -82.25%-421K | -937.02%-4.03M | ---231K | 98.52%-389K | ---- | 91.87%-26.22M | 64.88%-17.82M | 69.12%-322.6M | 88.89%-50.76M | -185.28%-1.04B |
| Interest paid - financing | ---- | -20.75%-4.59M | -119.22%-3.19M | 66.12%-3.8M | 90.92%-1.46M | 68.99%-11.21M | 43.09%-16.05M | 68.98%-36.14M | 65.58%-28.21M | -48.27%-116.5M |
| Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---- | ---- | ---116K | ---- | ---- | ---- | 37.55%-17.79M |
| Other items of the financing business | ---- | ---- | ---634K | 46.31%-3.64M | ---- | -989.09%-6.79M | ---- | 75.21%-623K | 100.00%-9K | -4,308.77%-2.51M |
| Net cash from financing operations | 90.31%-421K | -95.77%3M | -158.69%-4.35M | 1,469.09%70.91M | 90.45%-1.68M | -98.02%4.52M | 70.82%-17.6M | -29.37%228.05M | 82.03%-60.3M | 1.03%322.87M |
| Effect of rate | 135.14%13K | -64.71%-28K | -270.00%-37K | 79.27%-17K | -100.03%-10K | -108.41%-82K | 387.69%38.34M | 113.36%975K | -23,478.95%-13.33M | -2,318.54%-7.3M |
| Net Cash | -182.17%-2.75M | -192.06%-14.69M | -66.26%3.34M | 268.28%15.95M | 122.90%9.91M | 73.92%-9.48M | -370.78%-43.27M | -260.44%-36.34M | 48.11%-9.19M | 79.24%-10.08M |
| Begining period cash | -80.29%3.61M | 666.50%18.33M | 666.50%18.33M | -80.00%2.39M | -80.00%2.39M | -74.74%11.95M | -74.74%11.95M | -26.86%47.32M | -26.86%47.32M | -42.71%64.7M |
| Cash at the end | -95.93%880K | -80.29%3.61M | 76.06%21.63M | 666.50%18.33M | 74.90%12.29M | -80.00%2.39M | -71.68%7.03M | -74.74%11.95M | -47.28%24.81M | -26.86%47.32M |
| Cash balance analysis | ||||||||||
| Cash and bank balance | ---- | ---- | ---- | ---- | 74.90%12.29M | ---- | --7.03M | ---- | ---- | ---- |
| Cash and cash equivalent balance | ---- | ---- | ---- | ---- | 74.90%12.29M | ---- | --7.03M | ---- | ---- | ---- |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Auditor | -- | -- | -- | -- | -- | -- | -- | Zhonghui Anda Certified Public Accountants Co., Ltd. | -- | Zhonghui Anda Certified Public Accountants Co., Ltd. |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.